Sanofi Aventis Us Drug Patent Portfolio

Sanofi Aventis Us owns 16 orange book drugs protected by 88 US patents with Ambien Cr having the least patent protection, holding only 2 patents. And Apidra Solostar with maximum patent protection, holding 23 patents. Given below is the list of Sanofi Aventis Us's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9186346 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients 04 Aug, 2034
Active
US9186346 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients 04 Feb, 2034
Active
US9717852 Cartridge holder and pen-type injector 08 Apr, 2033
Active
US8602215 Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation 30 Jun, 2031
Active
US8927592 Antitumoral use of cabazitaxel 27 Apr, 2031
Active
US8802735 (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability 14 Mar, 2031
Active
US10583110 Antitumoral use of cabazitaxel 27 Oct, 2030
Active
US10716777 Antitumoral use of cabazitaxel 27 Oct, 2030
Active
US8927592 Antitumoral use of cabazitaxel 27 Oct, 2030
Active
US8802735 (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability 14 Sep, 2030
Active
US8410167 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality 16 Apr, 2029
Active
US9107900 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality 16 Apr, 2029
Active
US7918833 Pen-type injector 23 Mar, 2028
Active
US7918833 Pen-type injector 23 Sep, 2027
Active
US6794410 Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis 12 Mar, 2027
Active
US6794410 Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis 12 Sep, 2026
Active
US7241907 Acetone solvate of dimethoxy docetaxel and its process of preparation 10 Jun, 2026
Active
US7241907 Acetone solvate of dimethoxy docetaxel and its process of preparation 10 Dec, 2025
Active
US8679069 Pen-type injector 12 Apr, 2025
Active
US8512297 Pen-type injector 15 Sep, 2024 Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024 Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024 Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024 Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024 Expired
US8992486 Pen-type injector 05 Jun, 2024 Expired
US9011391 Pen-type injector 26 Mar, 2024 Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024 Expired
US8603044 Pen-type injector 02 Mar, 2024 Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024 Expired
US9408979 Pen-type injector 02 Mar, 2024 Expired
US9526844 Pen-type injector 02 Mar, 2024 Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired
US9775954 Pen-type injector 02 Mar, 2024 Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired
US7476652 Acidic insulin preparations having improved stability 23 Jan, 2024 Expired
US7713930 Acidic insulin preparations having improved stability 13 Dec, 2023 Expired
US7476652 Acidic insulin preparations having improved stability 23 Jul, 2023 Expired
US7713930 Acidic insulin preparations having improved stability 13 Jun, 2023 Expired
US6960561 Zinc-free and low-zinc insulin preparations having improved stability 25 Jan, 2023 Expired
US7148207 Oral fludara of high-purity formulation with quick release of active ingredient 20 Dec, 2022 Expired
US7452860 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022 Expired
US7696162 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022 Expired
US5847170 Taxoids, their preparation and pharmaceutical compositions containing them 26 Sep, 2021 Expired
US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof 01 Jun, 2020 Expired
US6429210 Polymorphic clopidogrel hydrogenesulphate form 10 Dec, 2019 Expired
US6504030 Polymorphic form of clopidogrel hydrogen sulphate 10 Dec, 2019 Expired
US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof 01 Dec, 2019 Expired
US6429210 Polymorphic clopidogrel hydrogenesulphate form 10 Jun, 2019 Expired
US6504030 Polymorphic form of clopidogrel hydrogen sulphate 10 Jun, 2019 Expired
US7547776 Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5% 10 Dec, 2018 Expired
US7323493 Solid pharmaceutical composition containing benzofuran derivatives 19 Jun, 2018 Expired
US8318800 Solid pharmaceutical compositions containing benzofuran derivatives 19 Jun, 2018 Expired
US6221633 Insulin derivatives having a rapid onset of action 18 Jun, 2018 Expired
US5635485 Erythromycin compounds 01 Apr, 2018 Expired
US5420319 Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same 09 Feb, 2017 Expired
US5420319 Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same 09 Aug, 2016 Expired
US5223510 Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them 26 Jul, 2016 Expired
US5976573 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US6143329 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US7977045 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US5847170 Taxoids, their preparation and pharmaceutical compositions containing them 26 Mar, 2016 Expired
US6331635 Taxoids, their preparation and pharmaceutical compositions containing them 26 Mar, 2016 Expired
US6372780 Methods of treating cell lines expressing multidrug resistance P-glycoprotein 26 Mar, 2016 Expired
US6387946 Methods for treating pathological conditions of abnormal cell proliferation 26 Mar, 2016 Expired
US5716988 Pharmaceutically stable preparation of oxaliplatinum 07 Feb, 2016 Expired
US5994348 Pharmaceutical compositions containing irbesartan 07 Dec, 2015 Expired
US6342247 Pharmaceutical compositions containing irbesartan 07 Dec, 2015 Expired
USD459798 Pill tablet 24 Sep, 2015 Expired
US5716988 Pharmaceutically stable preparation of oxaliplatinum 07 Aug, 2015 Expired
US5994348 Pharmaceutical compositions containing irbesartan 07 Jun, 2015 Expired
US6342247 Pharmaceutical compositions containing irbesartan 07 Jun, 2015 Expired
US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile 12 Feb, 2015 Expired
US5679709 Medicaments to combat autoimmune diseases 21 Oct, 2014 Expired
US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile 12 Aug, 2014 Expired
US5438072 Taxoid-based compositions 22 May, 2014 Expired
US5438072 Taxoid-based compositions 22 Nov, 2013 Expired
US5338874 Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity 07 Oct, 2013 Expired
US5290961 Platinum compound and process of preparing same 12 Jul, 2013 Expired
US5338874 Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity 07 Apr, 2013 Expired
US5290961 Platinum compound and process of preparing same 12 Jan, 2013 Expired
US5698582 Compositions containing taxane derivatives 03 Jan, 2013 Expired
US5714512 Compositions containing taxane derivatives 03 Jan, 2013 Expired
US5750561 Compositions containing taxane derivatives 03 Jan, 2013 Expired
US5459163 Medicament to combat autoimmune diseases 17 Oct, 2012 Expired
US5698582 Compositions containing taxane derivatives 03 Jul, 2012 Expired
US5714512 Compositions containing taxane derivatives 03 Jul, 2012 Expired
US5750561 Compositions containing taxane derivatives 03 Jul, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Sanofi Aventis Us.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 19 Jun, 2024 US9533105
Payment of Maintenance Fee, 8th Year, Large Entity 19 Jun, 2024 US9533105
Payment of Maintenance Fee, 8th Year, Large Entity 25 Jan, 2024 US9408979
Payment of Maintenance Fee, 8th Year, Large Entity 25 Jan, 2024 US9408979
Payment of Maintenance Fee, 4th Year, Large Entity 03 Jan, 2024 US10716777
Payment of Maintenance Fee, 4th Year, Large Entity 23 Aug, 2023 US10583110
Payment of Maintenance Fee, 8th Year, Large Entity 28 Jun, 2023 US9233211 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 28 Jun, 2023 US9233211 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 01 Feb, 2023 US9107900
Payment of Maintenance Fee, 8th Year, Large Entity 05 Oct, 2022 US9011391 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 05 Oct, 2022 US9011391 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 21 Sep, 2022 US7918833 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 21 Sep, 2022 US7918833 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 14 Sep, 2022 US8992486 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 14 Sep, 2022 US8992486 (Litigated)


Sanofi Aventis Us's Drug Patent Litigations

Sanofi Aventis Us's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Feb 17, 2016, against patent number US5847170. The petitioner Mylan Laboratories Limited, challenged the validity of this patent, with Aventis Pharma S.A. as the respondent. Click below to track the latest information on how companies are challenging Sanofi Aventis Us's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8679069 May, 2019 FWD Entered
(11 Aug, 2020)
Sanofi-Aventis Deutschland Pfizer Inc.
US8603044 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 October, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US9526844 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc
US9526844 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US9604008 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8679069 September, 2018 FWD Entered
(02 Apr, 2020)
Sanofi-Aventis Deutshland GmbH Mylan Pharmaceuticals Inc.
US9526844 May, 2019 Terminated-Other
(20 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US9526844 May, 2019 Terminated-Other
(19 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US8603044 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US8992486 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US9604008 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US5847170 October, 2018 Terminated-Denied
(06 May, 2019)
Aventis Pharma S.A. Neptune Generics, LLC
US9526844 September, 2018 Terminated-Denied
(03 Apr, 2019)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 September, 2018 Terminated
(19 Dec, 2018)
Sanofi-Aventis Deutschland GmbH et al. Mylan Pharmaceuticals Inc et al.
US7476652 June, 2017 FWD Entered
(12 Dec, 2018)
Sanofi Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.,
US7713930 June, 2017 FWD Entered
(12 Dec, 2018)
Sanofi Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.,
US8927592 March, 2016 Final Written Decision
(21 Sep, 2017)
AVENTIS PHARMA S.A. et al. Mylan Laboratories Limited et al.
US5847170 February, 2016 Terminated-Denied
(23 Aug, 2016)
Aventis Pharma S.A. Mylan Laboratories Limited


Sanofi Aventis Us Drug Patents' Oppositions Filed in EPO

Sanofi Aventis Us drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Oct 14, 2013, by Stada Arzneimittel Ag. This opposition was filed on patent number EP04787385A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP10782039A Dec, 2021 Maiwald Patent- und Rechtsanwaltsgesellschaft mbH Granted and Under Opposition
EP10782039A Dec, 2021 STADA Arzneimittel AG Granted and Under Opposition
EP10782039A Dec, 2021 Vossius & Partner Patentanwälte Rechtsanwälte mbB Granted and Under Opposition
EP10782039A Jun, 2021 Generics (U.K.) Limited Granted and Under Opposition
EP10782039A Mar, 2021 Dr. Reddy's Laboratories Ltd./ Betapharm Arzneimittel GmbH Granted and Under Opposition
EP10782039A Mar, 2021 Fresenius Kabi Deutschland GmbH Granted and Under Opposition
EP10782039A Mar, 2021 medac Gesellschaft für klinische Spezialpräparate mbH Granted and Under Opposition
EP10782039A Mar, 2021 Zentiva k.s. Granted and Under Opposition
EP10782039A Mar, 2021 EVER Valinject GmbH Granted and Under Opposition
EP10782039A Mar, 2021 Glenmark Pharmaceuticals Europe Ltd Granted and Under Opposition
EP10782039A Mar, 2021 Teva Pharmaceutical Industries Ltd. Granted and Under Opposition
EP10782039A Mar, 2021 Accord Healthcare Ltd Granted and Under Opposition
EP10752585A Jan, 2018 Pentafarma Sociedade Técnico-Medicinal S.A. Revoked
EP10752585A Dec, 2017 Wuesthoff & Wuesthoff Patentanwälte PartG mbB Revoked
EP10752585A Dec, 2017 Cooke, Richard Revoked
EP04787385A Oct, 2013 STADA Arzneimittel AG Opposition rejected


Sanofi Aventis Us's Family Patents

Sanofi Aventis Us drugs have patent protection in a total of 56 countries. It's US patent count contributes only to 17.6% of its total global patent coverage. 18 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sanofi Aventis Us Drug List

Given below is the complete list of Sanofi Aventis Us's drugs and the patents protecting them.


1. Ambien Cr

Ambien Cr is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6514531
(Pediatric)
Controlled-release dosage forms comprising zolpidem or a salt thereof 01 Jun, 2020
(4 years ago)
Expired
US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof 01 Dec, 2019
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ambien Cr's drug page


2. Apidra

Apidra is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6960561 Zinc-free and low-zinc insulin preparations having improved stability 25 Jan, 2023
(1 year, 8 months ago)
Expired
US7452860 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022
(2 years ago)
Expired
US7696162 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022
(2 years ago)
Expired
US6221633 Insulin derivatives having a rapid onset of action 18 Jun, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Apidra's drug page


3. Apidra Solostar

Apidra Solostar is protected by 23 patents, out of which 20 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9717852 Cartridge holder and pen-type injector 08 Apr, 2033
(8 years from now)
Active
US7918833 Pen-type injector 23 Sep, 2027
(2 years from now)
Active
US8679069 Pen-type injector 12 Apr, 2025
(5 months from now)
Active
US8512297 Pen-type injector 15 Sep, 2024
(29 days ago)
Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024
(a month ago)
Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024
(a month ago)
Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024
(a month ago)
Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024
(a month ago)
Expired
US8992486 Pen-type injector 05 Jun, 2024
(4 months ago)
Expired
US9011391 Pen-type injector 26 Mar, 2024
(6 months ago)
Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024
(7 months ago)
Expired
US8603044 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9408979 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9526844 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired
US9775954 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired
US6960561 Zinc-free and low-zinc insulin preparations having improved stability 25 Jan, 2023
(1 year, 8 months ago)
Expired
US7452860 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022
(2 years ago)
Expired
US7696162 Zinc-free and low-zinc insulin preparations having improved stability 22 Mar, 2022
(2 years ago)
Expired
US6221633 Insulin derivatives having a rapid onset of action 18 Jun, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Apidra Solostar's drug page


4. Aubagio

Aubagio is protected by 8 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9186346
(Pediatric)
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients 04 Aug, 2034
(9 years from now)
Active
US9186346 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients 04 Feb, 2034
(9 years from now)
Active
US8802735
(Pediatric)
(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability 14 Mar, 2031
(6 years from now)
Active
US8802735 (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability 14 Sep, 2030
(5 years from now)
Active
US6794410
(Pediatric)
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis 12 Mar, 2027
(2 years from now)
Active
US6794410 Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis 12 Sep, 2026
(1 year, 10 months from now)
Active
US5679709 Medicaments to combat autoimmune diseases 21 Oct, 2014
(9 years ago)
Expired
US5459163 Medicament to combat autoimmune diseases 17 Oct, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aubagio's drug page


5. Avalide

Avalide is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5994348
(Pediatric)
Pharmaceutical compositions containing irbesartan 07 Dec, 2015
(8 years ago)
Expired
US5994348 Pharmaceutical compositions containing irbesartan 07 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avalide's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Avapro

Avapro is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6342247
(Pediatric)
Pharmaceutical compositions containing irbesartan 07 Dec, 2015
(8 years ago)
Expired
US6342247 Pharmaceutical compositions containing irbesartan 07 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avapro's drug page


7. Eloxatin

Eloxatin is protected by 8 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5420319
(Pediatric)
Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same 09 Feb, 2017
(7 years ago)
Expired
US5420319 Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same 09 Aug, 2016
(8 years ago)
Expired
US5716988
(Pediatric)
Pharmaceutically stable preparation of oxaliplatinum 07 Feb, 2016
(8 years ago)
Expired
US5716988 Pharmaceutically stable preparation of oxaliplatinum 07 Aug, 2015
(9 years ago)
Expired
US5338874
(Pediatric)
Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity 07 Oct, 2013
(11 years ago)
Expired
US5290961
(Pediatric)
Platinum compound and process of preparing same 12 Jul, 2013
(11 years ago)
Expired
US5338874 Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity 07 Apr, 2013
(11 years ago)
Expired
US5290961 Platinum compound and process of preparing same 12 Jan, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eloxatin's drug page


8. Jevtana Kit

Jevtana Kit is protected by 13 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8927592
(Pediatric)
Antitumoral use of cabazitaxel 27 Apr, 2031
(6 years from now)
Active
US10583110 Antitumoral use of cabazitaxel 27 Oct, 2030
(6 years from now)
Active
US10716777 Antitumoral use of cabazitaxel 27 Oct, 2030
(6 years from now)
Active
US8927592 Antitumoral use of cabazitaxel 27 Oct, 2030
(6 years from now)
Active
US7241907
(Pediatric)
Acetone solvate of dimethoxy docetaxel and its process of preparation 10 Jun, 2026
(1 year, 7 months from now)
Active
US7241907 Acetone solvate of dimethoxy docetaxel and its process of preparation 10 Dec, 2025
(1 year, 1 month from now)
Active
US5847170
(Pediatric)
Taxoids, their preparation and pharmaceutical compositions containing them 26 Sep, 2021
(3 years ago)
Expired
US5847170 Taxoids, their preparation and pharmaceutical compositions containing them 26 Mar, 2016
(8 years ago)
Expired
US6331635 Taxoids, their preparation and pharmaceutical compositions containing them 26 Mar, 2016
(8 years ago)
Expired
US6372780 Methods of treating cell lines expressing multidrug resistance P-glycoprotein 26 Mar, 2016
(8 years ago)
Expired
US6387946 Methods for treating pathological conditions of abnormal cell proliferation 26 Mar, 2016
(8 years ago)
Expired
US5438072 Taxoid-based compositions 22 Nov, 2013
(10 years ago)
Expired
US5698582 Compositions containing taxane derivatives 03 Jul, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jevtana Kit's drug page


9. Ketek

Ketek is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5635485 Erythromycin compounds 01 Apr, 2018
(6 years ago)
Expired
USD459798 Pill tablet 24 Sep, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ketek's drug page


10. Lantus

Lantus is protected by 8 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7918833
(Pediatric)
Pen-type injector 23 Mar, 2028
(3 years from now)
Active
US7918833 Pen-type injector 23 Sep, 2027
(2 years from now)
Active
US7476652
(Pediatric)
Acidic insulin preparations having improved stability 23 Jan, 2024
(8 months ago)
Expired
US7713930
(Pediatric)
Acidic insulin preparations having improved stability 13 Dec, 2023
(10 months ago)
Expired
US7476652 Acidic insulin preparations having improved stability 23 Jul, 2023
(1 year, 2 months ago)
Expired
US7713930 Acidic insulin preparations having improved stability 13 Jun, 2023
(1 year, 4 months ago)
Expired
US5656722
(Pediatric)
A21 -, B30 - modified insulin derivatives having an altered action profile 12 Feb, 2015
(9 years ago)
Expired
US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile 12 Aug, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lantus's drug page


11. Lantus Solostar

Lantus Solostar is protected by 18 patents, out of which 16 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9717852 Cartridge holder and pen-type injector 08 Apr, 2033
(8 years from now)
Active
US8679069 Pen-type injector 12 Apr, 2025
(5 months from now)
Active
US8512297 Pen-type injector 15 Sep, 2024
(29 days ago)
Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024
(a month ago)
Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024
(a month ago)
Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024
(a month ago)
Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024
(a month ago)
Expired
US8992486 Pen-type injector 05 Jun, 2024
(4 months ago)
Expired
US9011391 Pen-type injector 26 Mar, 2024
(6 months ago)
Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024
(7 months ago)
Expired
US8603044 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9408979 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9526844 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired
US9775954 Pen-type injector 02 Mar, 2024
(7 months ago)
Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lantus Solostar's drug page


12. Multaq

Multaq is protected by 6 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8602215 Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation 30 Jun, 2031
(6 years from now)
Active
US8410167 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality 16 Apr, 2029
(4 years from now)
Active
US9107900 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality 16 Apr, 2029
(4 years from now)
Active
US7323493 Solid pharmaceutical composition containing benzofuran derivatives 19 Jun, 2018
(6 years ago)
Expired
US8318800 Solid pharmaceutical compositions containing benzofuran derivatives 19 Jun, 2018
(6 years ago)
Expired
US5223510 Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them 26 Jul, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Multaq's drug page


13. Nasacort Aq

Nasacort Aq is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5976573 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired
US6143329 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired
US7977045 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nasacort Aq's drug page


14. Oforta

Oforta is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7148207 Oral fludara of high-purity formulation with quick release of active ingredient 20 Dec, 2022
(1 year, 9 months ago)
Expired
US7547776 Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5% 10 Dec, 2018
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oforta's drug page


15. Plavix

Plavix is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6429210
(Pediatric)
Polymorphic clopidogrel hydrogenesulphate form 10 Dec, 2019
(4 years ago)
Expired
US6504030
(Pediatric)
Polymorphic form of clopidogrel hydrogen sulphate 10 Dec, 2019
(4 years ago)
Expired
US6429210 Polymorphic clopidogrel hydrogenesulphate form 10 Jun, 2019
(5 years ago)
Expired
US6504030 Polymorphic form of clopidogrel hydrogen sulphate 10 Jun, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Plavix's drug page


16. Taxotere

Taxotere is protected by 8 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5438072
(Pediatric)
Taxoid-based compositions 22 May, 2014
(10 years ago)
Expired
US5438072 Taxoid-based compositions 22 Nov, 2013
(10 years ago)
Expired
US5698582
(Pediatric)
Compositions containing taxane derivatives 03 Jan, 2013
(11 years ago)
Expired
US5714512
(Pediatric)
Compositions containing taxane derivatives 03 Jan, 2013
(11 years ago)
Expired
US5750561
(Pediatric)
Compositions containing taxane derivatives 03 Jan, 2013
(11 years ago)
Expired
US5698582 Compositions containing taxane derivatives 03 Jul, 2012
(12 years ago)
Expired
US5714512 Compositions containing taxane derivatives 03 Jul, 2012
(12 years ago)
Expired
US5750561 Compositions containing taxane derivatives 03 Jul, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Taxotere's drug page